Dr. DEVOS MD: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Dr. DEVOS MD
Largest movements
- Cash -€1,447
down €1,447 (-34.6%), from €4,184 to €2,737
mainly Net result for the year (-€4,762)
- Profit (loss) carried forward -€4,762
down €4,762 (-8.0%), from -€59,295 to -€64,057
- Other debts +€3,315
up €3,315 (+70.9%), from €4,674 to €7,988
- Gross operating margin -€7,592
down €7,592, from €3,049 to -€4,543
- Depreciation -€127
no longer reported in 2025 (was €127)
- Other operating charges -€88
down €88 (-42.4%), from €208 to €120
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,184 | €2,737 | -€1,447 | -34.6% |
| Current assets | 29/58 | €4,184 | €2,737 | -€1,447 | -34.6% |
| Cash at bank and in hand | 54/58 | €4,184 | €2,737 | -€1,447 | -34.6% |
| Total equity and liabilities | 10/49 | €4,184 | €2,737 | -€1,447 | -34.6% |
| Equity | 10/15 | -€37,735 | -€42,497 | -€4,762 | -12.6% |
| Contributions | 10/11 | €19,600 | €19,600 | = | 0.0% |
| Capital | 10 | €19,600 | - | -€19,600 | |
| Issued capital | 100 | €19,600 | - | -€19,600 | |
| Outside capital | 11 | - | €19,600 | +€19,600 | |
| Share premium | 1100/10 | - | €19,600 | +€19,600 | |
| Reserves | 13 | €1,960 | €1,960 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,960 | €1,960 | = | 0.0% |
| Legal reserve | 130 | €1,960 | €1,960 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€59,295 | -€64,057 | -€4,762 | -8.0% |
| Amounts payable | 17/49 | €41,919 | €45,233 | +€3,315 | +7.9% |
| Amounts payable after more than one year | 17 | €37,245 | €37,245 | = | 0.0% |
| Other amounts payable | 178/9 | €37,245 | €37,245 | = | 0.0% |
| Amounts payable within one year | 42/48 | €4,674 | €7,988 | +€3,315 | +70.9% |
| Other amounts payable | 47/48 | €4,674 | €7,988 | +€3,315 | +70.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €127 | - | -€127 | |
| Other operating charges | 640/8 | €208 | €120 | -€88 | -42.4% |
| Gross operating margin | 9900 | €3,049 | -€4,543 | -€7,592 | |
| Operating profit (loss) | 9901 | €2,713 | -€4,663 | -€7,377 | |
| Financial charges | 65/66B | €96 | €98 | +€3 | +2.7% |
| Recurring financial charges | 65 | €96 | €98 | +€3 | +2.7% |
| Profit (loss) for the period before taxes | 9903 | €2,618 | -€4,762 | -€7,379 | |
| Profit (loss) for the period | 9904 | €2,618 | -€4,762 | -€7,379 | |
| Profit (loss) for the period to be appropriated | 9905 | €2,618 | -€4,762 | -€7,379 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.